Background: This study explored the perspectives and experiences from patients and families around how patient/family preferences and priorities are considered in medication-related discussions and decisions within the healthcare system.
Methods: We conducted a qualitative study using focus groups with residents of Southern Ontario and British Columbia ( = 16). Three focus groups were conducted using a semi-structured focus group guide. The audiotaped focus group discussions were transcribed verbatim. A thematic analysis, using inductive coding, was completed.
Results: A total of three main themes [and several (and sub-sub-themes)] emerged from the data: patient and family expertise [, and (patient/family, healthcare provider)], perceived patient-centredness ( and ), and system (, and ). Stories told by participants helped to clarify the relationships between the themes and sub-themes, leading to, what we understand as around medications and subsequent health outcomes.
Conclusions: Our findings showed that shared decision-making resulted from both recognition and integration of the personal expertise of the patient and family in medications, and perceived patient-centredness. This is broadly consistent with the current conceptualization of evidence-based medicine. The stories told highlight the complex, dynamic, and nonlinear nature of shared decision-making for medications, and that patient priorities are not as integrated into shared decision-making about medications as we would hope. This suggests the need for developing a systematic process to elicit, record, and integrate patient preferences and priorities about medications to create space for a more patient-centred conversation.
}, year = {2019}, journal = {Ther Adv Drug Saf.}, volume = {10}, pages = {2042098619838796}, month = {12/2019}, issn = {2042-0986}, doi = {10.1177/2042098619838796}, language = {eng}, }